Legacy Education Announces Five-Year ACCET Reaccreditation for Contra Costa Medical Career College, Reinforcing Academic Quality

Rhea-AI Summary

Legacy Education (NYSE American: LGCY) announced that Contra Costa Medical Career College received a five-year reaccreditation from the Accrediting Council for Continuing Education & Training (ACCET) on April 30, 2026. The decision recognizes academic oversight, student outcomes, and institutional operations, and supports the college's stability and ability to scale healthcare programs.

Positive

• Five-year ACCET reaccreditation granted to Contra Costa Medical Career College
• Reaccreditation covers academic oversight, student outcomes, and operations
• Validates integration of the college as Legacy's most recent acquisition
• Supports ability to scale healthcare programs aligned with workforce demand

Negative

• None.

News Market Reaction – LGCY

-3.81%

6 alerts

-3.81% Session close to close

+11.4% Peak in 19 hr 51 min

$151.48M Market Cap

0.7x Rel. Volume

In the Apr 30 session, LGCY declined 3.81%, reflecting a moderate negative market reaction. Argus tracked a peak move of +11.4% during that session. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights a five-year ACCET reaccreditation for Contra Costa Medical Career Colle...

Analysis

This announcement highlights a five-year ACCET reaccreditation for Contra Costa Medical Career College, signaling sustained compliance with national standards and support for long-term institutional stability. In recent months, Legacy Education has paired similar quality validations with strong revenue and enrollment growth, as reflected in prior quarterly results. Investors may focus on how this reaccreditation supports program scalability, student outcomes, and integration of the December 2024 acquisition within the broader multi-campus healthcare education platform.

Key Figures

Reaccreditation term: five-year grant

1 metrics

Reaccreditation term five-year grant ACCET reaccreditation for Contra Costa Medical Career College

Historical Context

5 past events · Latest: Mar 17 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 17	Conference participation	Positive	+1.1%	Participation in 38th Annual ROTH Conference with investor meetings.
Feb 17	Accreditation update	Positive	+5.4%	Six-year reaccreditation for Integrity College of Health from ABHES.
Feb 12	Earnings results	Positive	+15.0%	Strong Q2 FY2026 revenue, enrollment, EBITDA and net income growth.
Feb 05	Leadership change	Positive	-1.0%	Appointment of SVP of Operations to manage scalable multi-campus growth.
Jan 27	Earnings scheduling	Neutral	-4.5%	Announcement of date and access details for Q2 earnings release call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent LGCY news has mostly seen aligned reactions, with strong positive moves on earnings and accreditation updates and one divergence on a leadership hire.

Recent Company History

Over the last few months, Legacy Education has reported strong financial growth, leadership expansion, conference participation, and accreditation wins. Q2 FY2026 results on Feb 12, 2026 produced a 15.04% move after highlighting revenue and enrollment gains. A six-year reaccreditation for Integrity College of Health on Feb 17, 2026 preceded a 5.37% rise. Today’s five-year ACCET reaccreditation for Contra Costa Medical Career College continues the theme of reinforcing academic quality and institutional stability across its healthcare education portfolio.

Key Terms

reaccreditation, accrediting council for continuing education & training

2 terms

reaccreditation regulatory

"has received a five-year grant of reaccreditation from the Accrediting Council"

Reaccreditation is the formal renewal of an organization’s certified status by an independent authority after a periodic review of its practices, records and facilities. Like renewing a driver’s license after demonstrating you still meet the rules, it matters to investors because a successful reaccreditation confirms ongoing compliance, preserves the right to operate or bill for services, and reduces regulatory and reputational risk—while a failed or delayed reaccreditation can threaten revenue and valuation.

accrediting council for continuing education & training regulatory

"from the Accrediting Council for Continuing Education & Training (ACCET)."

An accrediting council for continuing education & training is an independent organization that reviews and approves professional training programs to ensure they meet published standards for quality, relevance, and integrity. Investors care because accreditation acts like a consumer report card for workforce development—trusted programs reduce regulatory and legal risk, help maintain professional certifications, and improve employee skills and productivity, which can affect a company’s performance and reputation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LANCASTER, Calif., April 30, 2026 /PRNewswire/ -- Legacy Education Inc. ("Legacy Education" or the "Company") (NYSE American: LGCY), a leading provider of career education healthcare programs, proudly announces that Contra Costa Medical Career College (CCMCC) has received a five-year grant of reaccreditation from the Accrediting Council for Continuing Education & Training (ACCET).

The reaccreditation decision follows ACCET's comprehensive review and recognizes CCMCC's performance across academic oversight, student outcomes, and institutional operations. The five-year term reflects sustained alignment with national standards and reinforces the college's position as a high-quality career education provider.

Receiving the maximum reaccreditation term highlights CCMCC's ability to deliver consistent outcomes while maintaining disciplined compliance and operational execution. The result supports the long-term stability of the institution and its ability to scale programs aligned with workforce demand in healthcare.

"Achieving the full five-year reaccreditation from ACCET is an important milestone for Contra Costa Medical Career College, particularly as our most recent acquisition," said LeeAnn Rohmann, Chief Executive Officer of Legacy Education. "This outcome validates both the strength of the institution and our disciplined approach to integrating and growing high-quality assets that deliver strong student outcomes and long-term value."

About Contra Costa Medical Career College
Contra Costa Medical Career College is located in Antioch, California, is an accredited healthcare training institution and a Legacy Education Inc. school. The college offers career-focused programs in allied health, including vocational nursing, diagnostic medical sonography, medical assisting with phlebotomy, dental assisting, surgical technology, and sterile processing. CCMCC emphasizes hands-on training and real-world clinical experience to prepare students for in-demand healthcare careers and support strong employment outcomes. 

ABOUT LEGACY EDUCATION

Legacy Education (NYSE: LGCY) is an award-winning, nationally accredited, for-profit post-secondary education company founded in 2009. Legacy Education provides career-focused education primarily in the healthcare field, with certificates and degrees for nursing, sonography, medical technicians, dental assisting, business administration, and several others. The Company offers a wide range of educational programs and services to help students achieve their professional goals. Legacy Education's focus is on providing high-quality education that is accessible and affordable. Legacy Education is committed to growing its education footprint via organic enrollment growth, addition of new programs, and accretive acquisitions. For more information, please visit www.legacyed.com or on LinkedIn @legacy-education-inc.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the Company's operations. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty, and changes in circumstances. Actual results may differ materially from those indicated by these forward-looking statements because of various important factors, including, without limitation, market conditions and the factors described in the section entitled "Risk Factors" in Legacy's most recent Annual Report on Form 10-K and Legacy's other filings made with the U.S. Securities and Exchange Commission. All such statements speak only as of the date of this press release. Consequently, forward-looking statements should be regarded solely as Legacy's current plans, estimates, and beliefs. Legacy cannot guarantee future results, events, levels of activity, performance, or achievements. Legacy does not undertake and specifically declines any obligation to update or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law.

Contact Legacy Education Inc.
Investor Relations
ir@legacyed.com

Amato and Partners, LLC
Investors Relations Counsel
admin@amatoandpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/legacy-education-announces-five-year-accet-reaccreditation-for-contra-costa-medical-career-college-reinforcing-academic-quality-302758628.html

SOURCE Legacy Education Inc.

FAQ

What did Legacy Education (LGCY) announce about Contra Costa Medical Career College on April 30, 2026?

Contra Costa Medical Career College received a five-year reaccreditation from ACCET. According to the company, ACCET's review recognized academic oversight, student outcomes, and institutional operations, supporting the college's stability and program expansion.

What does a five-year ACCET reaccreditation mean for LGCY and CCMCC students?

It means sustained compliance with ACCET national standards for five years. According to the company, the term reflects consistent student outcomes and institutional operations, which helps protect program continuity and credibility for current and prospective students.

How does the ACCET reaccreditation affect Legacy Education's recent acquisition of CCMCC?

The reaccreditation confirms the acquired college meets ACCET standards for five years. According to the company, this outcome validates Legacy's integration approach and supports the institution's long-term stability and growth potential.

Will the reaccreditation allow CCMCC to expand healthcare programs under LGCY?

The five-year term supports the college's ability to scale programs aligned with workforce demand. According to the company, sustained alignment with standards and operational execution enables program development and potential enrollment growth.

Who granted the reaccreditation and which areas were evaluated for CCMCC's ACCET decision?

The Accrediting Council for Continuing Education & Training (ACCET) granted the five-year reaccreditation. According to the company, ACCET evaluated academic oversight, student outcomes, and institutional operations during its comprehensive review.